← Leaderboards
Kevin Jackson
Algometrx, Inc.
$334,552
Attributed
$669,103
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$669,103 · 2
By mechanism
R43$669,103 · 2
Top collaborators
- Julia Cole Finkel2 shared
Others in their field
Other Rising Stars on “Nociception”
- Thomas A. Anderson · Stanford University$2,505,537
- Wolfram Christian Poller · Icahn School Of Medicine At Mount Sinai$2,331,485
- Catherine M Cahill · University Of California Los Angeles$2,256,959
- Alejandra Mendoza · Scripps Research Institute, The$1,656,000
- Virginia J Sanders · Dimerx$1,593,126
- Jonathan Gasson · Cerevu Medical, Inc.$1,577,995
Research focus
NociceptionRisk MinimizationFiberNew TechnologyPublic HealthResponseDevicesEnrollmentMedical DeviceNerve FibersPharmaceutical PreparationsPhysiologicalPupilReportingClinical TrialsChildEarly DiagnosisElectric StimulationHospitalsIndexingAssessment ToolMonitorAfferent NerveSeverities
Grant awards (2)
Use of a novel physiologic measure for the assessment and monitoring of vincristine induced peripheral neuropathy (VIPN) in children and adolescents.$396,711
R43 · FY2022 · CA · contact PI
Development of a novel technology for the determination of a physiologic phenotype in patients with Systemic Lupus Erythematosus$272,392
R43 · FY2022 · AR · contact PI